Why Orphazyme Stock Skyrocketed 24.6% Today

·1 min read
Why Orphazyme Stock Skyrocketed 24.6% Today

Shares of Orphazyme (NASDAQ: ORPH) skyrocketed 24.6% as of the market close on Wednesday after rising as much as 56.6% earlier in the day. The big gain came after the drugmaker announced that Goldman Sachs (NYSE: GS) temporarily increased its stake to 5.58% on Jun. 16, 2021, but then reduced its position to less than 5% the following day. What does the "major shareholder announcement" made by Orphazyme today mean for investors?

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting